Oxford Angel Fund

Oxford Angel Fund

Palo Alto, Californiaoxfordentrepreneurs.net

Overview

The Oxford Angel Fund is an early-stage venture capital fund that invests in companies founded by Oxford University alumni. Founded in 2016, the fund initially started as a $500K experimental fund. It has since launched multiple funds, including Fund II (first close in 2020) and Fund III (first close in 2024). As of July 2024, the fund has rebranded to Oxonian Ventures to reflect its investment focus on pre-seed, seed, and Series A rounds. The fund collaborates closely with the Oxford Entrepreneurs Network for deal flow and due diligence. It invests primarily in US-based companies across a wide range of industries, including BioTech, FinTech, AI, and HealthTech.

Portfolio Companies

4

Investments

CompanyDateStageLead
Granza BioJul 2024SeedCo-investor
Valink TherapeuticsNov 2023SeedCo-investor
CNoteSep 2022Series ACo-investor
The BeansJun 2021SeedCo-investor
The BeansFeb 2020Pre SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersPalo Alto, California
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.